World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 12 December 2020
Main ID:  NCT04611464
Date of registration: 09/10/2020
Prospective Registration: No
Primary sponsor: Dallas VA Medical Center
Public title: Misoprostol for Spinal Stenosis
Scientific title: Pain and Functional Outcomes With Misoprostol Treatment for Lumbar Spinal Stenosis
Date of first enrolment: July 11, 2019
Target sample size: 23
Recruitment status: Completed
URL:  https://clinicaltrials.gov/show/NCT04611464
Study type:  Observational
Study design:   
Phase: 
Countries of recruitment
United States
Contacts
Key inclusion & exclusion criteria

Inclusion Criteria:

- Adults aged 18 years or older.

- Previous diagnosis of lumbar spinal stenosis, mild-severe lumbar central canal
stenosis identified by MRI or CT scan.

- Symptoms:

- Lower extremity symptoms consistent with neurogenic claudication.

- Pain, weakness &/or numbness triggered by standing or walking, and relieved by
sitting.

- Must be able to read English and complete questionnaire.

- Was prescribed Misoprostol specifically for lumbar spinal stenosis.

Exclusion Criteria:

- Cognitive impairment that renders the patient unable to give informed consent or
provide accurate data

- Clinical co-morbidities that could interfere with the collection of data concerning
pain and function

- Severe vascular, pulmonary, or coronary artery disease that limits ambulation
including recent myocardial infarction (within 6 months)

- Spinal instability requiring surgical fusion

- Severe osteoporosis as defined by multiple compression fractures or a fracture at the
same level as the stenosis

- Metastatic cancer

- Excessive alcohol consumption or evidence of non-prescribed or illegal drug use

- Pregnancy

- Concordant pain with internal rotation of the hip (or known hip joint pathology)

- Active local or systemic infection

- Previous lumbar spine surgery

- Prisoners

- Use of misoprostol for any other indication then lumbar spinal stenosis

- Rheumatological disorders such as rheumatoid arthritis, psoriatic arthritis, systemic
lupus erythematosis.



Age minimum: 18 Years
Age maximum: N/A
Gender: All
Health Condition(s) or Problem(s) studied
Low Back Pain
Lumbar Spinal Stenosis
Intervention(s)
Drug: Misoprostol
Primary Outcome(s)
Claudication Distance Assessment [Time Frame: Change from baseline, after they have been treated with Misoprostol]
Swiss Lumbar Spinal Stenosis Questionnaire(SSSQ) [Time Frame: Once at baseline, after they have been treated with Misoprostol; SSSQ has not been collected previously]
Oswestry Disability Index (ODI) [Time Frame: Change from baseline, after they have been treated with Misoprostol]
Secondary Outcome(s)
Secondary ID(s)
19-006
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history